comparemela.com
Home
Live Updates
Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL : comparemela.com
Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL
/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...
Related Keywords
Delaware ,
United States ,
Salt Lake City ,
Utah ,
Gregoryc Critchfield ,
Peter Denardo ,
Exchange Commission On ,
Sera Prognostics Inc ,
Prnewswire Sera Prognostics Inc ,
Nasdaq ,
Pregnancy Company ,
Prognostics Inc ,
Serum Assessment ,
Preterm Birth Outcomes Compared ,
Historical Controls ,
Proteomic Assessment ,
Preterm Risk ,
Multicenter Assessment ,
Spontaneous Preterm Birth Risk Predictor ,
Sera Prognostics ,
Dimes Report Card ,
Private Securities Litigation Reform Act ,
Final Prospectus ,
Exchange Commission ,
Quarterly Reports ,
Annual Reports ,
Current Reports ,
Nc ,
comparemela.com © 2020. All Rights Reserved.